UBS OCONNOR LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,234,791
+13.7%
1,176,710
+93.9%
0.03%
-5.9%
Q2 2023$1,086,011
-53.0%
606,710
+2.2%
0.03%
-52.1%
Q1 2023$2,309,901
-99.8%
593,805
+118.9%
0.07%
+153.6%
Q3 2022$1,481,000,000
+44.3%
271,219
+19.2%
0.03%
+86.7%
Q2 2022$1,026,000,000
+224.7%
227,599
+658.7%
0.02%
+150.0%
Q3 2015$316,000,000
-58.7%
30,000
+20.0%
0.01%
-62.5%
Q1 2015$765,000,00025,0000.02%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 6,491,812$122,955,0007.37%
Fairmount Funds Management LLC 652,351$12,356,0005.51%
Palo Alto Investors LP 4,219,452$79,916,0004.80%
Avoro Capital Advisors LLC 7,000,000$132,580,0002.62%
Birchview Capital, LP 168,000$3,182,0001.92%
EMERALD ADVISERS, LLC 1,244,211$23,565,0001.03%
EMERALD MUTUAL FUND ADVISERS TRUST 1,036,947$19,640,0000.93%
Hood River Capital Management LLC 1,007,367$19,080,0000.86%
Atlas Private Wealth Advisors 48,640$921,0000.82%
SPHERA FUNDS MANAGEMENT LTD. 392,831$7,440,0000.70%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders